News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
484,713 Results
Type
Article (8036)
Company Profile (141)
Press Release (476631)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166760)
Career Advice (305)
Deals (25740)
Drug Delivery (7)
Drug Development (52877)
Employer Resources (14)
FDA (9761)
Job Trends (8575)
News (238245)
Policy (17922)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (486)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33154)
ALS (105)
Alzheimer's disease (976)
Antibody-drug conjugate (ADC) (264)
Approvals (10378)
Artificial intelligence (321)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (262)
Best Places to Work (6958)
BIO (36)
Biologics (2)
BIOSECURE Act (1)
Biosimilars (109)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (138)
Brain cancer (29)
Breast cancer (510)
Cancer (3652)
Cardiovascular disease (218)
Career advice (245)
Career pathing (1)
CAR-T (174)
Celiac Disease (1)
Cell therapy (478)
Cervical cancer (34)
Clinical research (47875)
Collaboration (1245)
Commercialization (3)
Compensation (1470)
Complete response letters (34)
COVID-19 (754)
CRISPR (63)
C-suite (751)
Cystic fibrosis (85)
Data (5661)
Denatured (4)
Depression (102)
Dermatology (62)
Diabetes (344)
Diagnostics (4186)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (155)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (164)
Earnings (73716)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87625)
Executive appointments (702)
FDA (12399)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (919)
Gene editing (125)
Generative AI (9)
Gene therapy (318)
GLP-1 (290)
Government (942)
Grass and pollen (2)
Guidances (281)
Healthcare (9318)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (98)
Immuno-oncology (56)
Indications (157)
Infectious disease (942)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (255)
Interviews (41)
IPO (12387)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Licensing (8)
Liver cancer (44)
Longevity (17)
Lung cancer (509)
Lymphoma (251)
Machine learning (27)
Management (3)
Manufacturing (534)
Marketing (8)
MASH (118)
Medical device (8657)
Medtech (8802)
Mergers & acquisitions (14384)
Metabolic disorders (709)
mRNA (55)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (39)
Neuroscience (1826)
NextGen: Class of 2026 (3150)
Non-profit (842)
Obesity (225)
Opinion (10)
Ovarian cancer (159)
Pain (172)
Pancreatic cancer (197)
Parkinson's disease (201)
Partnered (12)
Patents (476)
Patient recruitment (508)
Peanut (31)
People (41241)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15470)
Phase 2 (21382)
Phase 3 (14400)
Pipeline (7344)
Policy (18)
Postmarket research (1570)
Preclinical (6540)
Press Release (34)
Prostate cancer (190)
Psychedelics (7)
Radiopharmaceuticals (189)
Rare diseases (575)
Real estate (3019)
Recruiting (6)
Regulatory (14830)
Reports (21)
Research institute (581)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (100)
Series A (156)
Series B (121)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (88)
Sponsored (5)
Startups (2019)
Stomach cancer (3)
Supply chain (50)
Vaccines (323)
Venture capital (17)
Weight loss (73)
Women's health (79)
Date
Today (46)
Last 7 days (213)
Last 30 days (1581)
Last 365 days (19040)
2026 (12340)
2025 (19253)
2024 (22989)
2023 (26545)
2022 (34586)
2021 (37168)
2020 (33480)
2019 (23276)
2018 (17468)
2017 (18765)
2016 (17917)
2015 (24263)
2014 (21683)
2013 (18135)
2012 (20221)
2011 (20440)
2010 (20332)
Location
Africa (228)
Alabama (73)
Alaska (2)
Arizona (305)
Arkansas (11)
Asia (17896)
Australia (2098)
California (11989)
Canada (3148)
China (524)
Colorado (485)
Connecticut (409)
Delaware (208)
Europe (24636)
Florida (1789)
Georgia (380)
Hawaii (3)
Idaho (46)
Illinois (701)
India (51)
Indiana (314)
Iowa (15)
Japan (403)
Kansas (101)
Kentucky (30)
Louisiana (27)
Maine (26)
Maryland (1205)
Massachusetts (7861)
Michigan (308)
Minnesota (560)
Mississippi (4)
Missouri (82)
Montana (20)
Nebraska (11)
Nevada (116)
New Hampshire (60)
New Jersey (2621)
New Mexico (12)
New York (2822)
North Carolina (1280)
North Dakota (4)
Northern California (6003)
Ohio (278)
Oklahoma (14)
Oregon (18)
Pennsylvania (2253)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (76)
South Dakota (1)
Southern California (4983)
Tennessee (120)
Texas (1942)
United States (38909)
Utah (360)
Vermont (1)
Virginia (154)
Washington D.C. (38)
Washington State (929)
West Virginia (1)
Wisconsin (73)
Wyoming (1)
484,713 Results for "theradaptive inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Theradaptive Announces Final Patient Enrolled in RESTORE Feasibility Study Evaluating OsteoAdapt® DE in Dental Procedures
April 23, 2026
·
3 min read
Press Releases
Theradaptive Secures FDA Approval to Advance OASIS Trial to Pivotal Study Evaluating OsteoAdapt® SP in Spinal Fusion
April 30, 2026
·
4 min read
Press Releases
ATEC and Theradaptive Enter Strategic Partnership for Breakthrough Regenerative Technology in Spinal Fusion
January 13, 2026
·
4 min read
Press Releases
Theradaptive Treats First Patient in RESTORE Feasibility Study Evaluating OsteoAdapt™ DE in Dental Procedures
August 27, 2025
·
4 min read
Press Releases
Theradaptive Appoints Daniel Wolf as Chief Financial Officer, Continuing Executive Transformation
April 22, 2025
·
3 min read
Press Releases
Theradaptive Welcomes Jeffrey W. Dunn to its Board of Directors
March 17, 2025
·
3 min read
BioCapital
Theradaptive Secures Landmark Funding from Maryland Stem Cell Research Fund (MSCRF) to Support Human Clinical Trials
Theradaptive, Inc., a regenerative medicine company developing targeted therapeutics, announced it has been awarded funding from the Maryland Stem Cell Research Fund to support human clinical trials for its lead product, OsteoAdapt SP.
May 22, 2024
·
3 min read
Drug Development
U.S. FDA GRANTS THERADAPTIVE IDE APPROVAL FOR PHASE I/II CLINICAL TRIALS
Theradaptive, the market leader in targeted regenerative therapeutics, has gained approval from the U.S. Food and Drug Administration (FDA) for their Investigational Device Exemption (IDE) submission to begin enrolling patients into OASIS, their global Phase I/II Feasibility study in spine fusion.
February 1, 2024
·
5 min read
Press Releases
Theradaptive Obtains FDA IDE Approval to Study OsteoAdapt™ SP in Additional Spinal Fusion Indications
December 10, 2024
·
3 min read
BioCapital
Theradaptive Closes $26 Million Series A Investment Round
Theradaptive, a biopharmaceutical company breaking new ground in targeted regenerative therapeutics, announces that it has closed a $26 million Series A funding round to advance development of its targeted regenerative therapeutics.
June 15, 2023
·
3 min read
1 of 48,472
Next
